Global Liver Institute

News

GLOBAL LIVER INSTITUTE

News
Public Witness Testimony, Donna Cryer

Public Witness Testimony, Donna Cryer

GLI CEO Donna R. Cryer addresses the concerns of the liver disease community about the senseless rising incidence of liver disease and liver cancers when measures to prevent, diagnose, and treat liver disease and liver cancer are available.

read more
Educate Yourself

Educate Yourself

At GLI, we strive to keep you up to date and in-the-know with the latest in the field of liver cancers.

read more
Advancements in Rare Liver Disease Treatment

Advancements in Rare Liver Disease Treatment

Thanks to the dedication of researchers and innovators, patients with several rare liver diseases can find hope in the promise of new treatments on the horizon – great news on the heels of Rare Liver Diseases Month.

read more
A Critical Time in NASH

A Critical Time in NASH

With NASH drug approval in the US on the horizon, energy has been high throughout the field. Nevertheless, we still face challenges – regulatory science must be aligned, and advocacy among stakeholders must be employed to help patients understand what to expect once we enter this new stage of NASH treatments.

read more